Eli Lilly

• 1/16/2025

  Eli Lilly’s Q4 Revenue Guidance Falls Short, Shares Tumble 6%

• 1/16/2025

  Biotech Boom: 5 Trends to Watch in 2025

• 1/15/2025

  Cramer’s Contrarian Call: Seizing Opportunity in Eli Lilly’s Dip

• 1/15/2025

  Revolutionizing Weight Loss: Eli Lilly’s Breakthrough Pill

• 1/8/2025

  Weight Loss Showdown: Viking Therapeutics Faces Off Against Merck

• 1/5/2025

  Beat the Market with High-Growth Trends and Top Stocks

• 12/26/2024

  Obesity Drug Setback Sparks Retail Rush into Novo Nordisk

• 12/24/2024

  Eli Lilly’s Unstoppable Rise: A Pharmaceutical Powerhouse

• 12/23/2024

  FDA Greenlights Revolutionary Sleep Apnea Treatment, Offering New Hope to Millions

• 12/23/2024

  Tirzepatide Shortage Ends: What It Means for Patients and Pharmacies